34270-10-5

Basic information

• Product Name: [(2R,3R,4S)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methyl benzoate
• Synonyms: [(2R,3R,4S)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methyl benzoate
• CAS NO: 34270-10-5
• Molecular Formula: C₁₆H₁₇N₃O₆
• Molecular Weight: 0
• Mol File: 34270-10-5.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 594.9°Cat760mmHg
• Flash Point: 313.6°C
• Appearance: /
• Density: 1.58g/cm³
• Vapor Pressure: 5.33E-15mmHg at 25°C
• Refractive Index: 1.69
• CAS DataBase Reference: [(2R,3R,4S)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methyl benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: [(2R,3R,4S)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methyl benzoate(34270-10-5)
• EPA Substance Registry System: [(2R,3R,4S)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methyl benzoate(34270-10-5)

Safety Data

• Hazardous Substances Data: 34270-10-5(Hazardous Substances Data)

Usage

Description

[(2R,3R,4S)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methyl benzoate is a complex organic molecule that features a sugar (oxolan) and a pyrimidine derivative (4-amino-2-oxo-pyrimidin-1-yl), along with a methyl benzoate group. [(2R,3R,4S)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methyl benzoate may hold potential pharmaceutical applications due to the presence of a pyrimidine moiety, which is a common structural element in numerous drugs. The combination of a sugar and a benzoate group could also result in unique properties, such as enhanced solubility or bioavailability.

Uses

Used in Pharmaceutical Industry:
[(2R,3R,4S)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methyl benzoate is used as a potential pharmaceutical compound for its possible applications in drug development. The presence of a pyrimidine moiety suggests that it could be utilized in the creation of new medications, particularly those targeting various diseases or conditions. [(2R,3R,4S)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methyl benzoate's specific role and effectiveness would require further research and testing.
Used in Drug Solubility and Bioavailability Enhancement:
In the pharmaceutical industry, [(2R,3R,4S)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl ]methyl benzoate may also be used to improve the solubility and bioavailability of other drugs. The combination of a sugar and a benzoate group could potentially enhance the compound's interaction with biological systems, leading to better absorption and distribution of the drug within the body. This application would also necessitate additional research and development to fully understand and optimize its potential benefits.

InChI:InChI=1/C16H17N3O6/c17-11-6-7-19(16(23)18-11)14-13(21)12(20)10(25-14)8-24-15(22)9-4-2-1-3-5-9/h1-7,10,12-14,20-21H,8H2,(H2,17,18,23)/t10-,12-,13+,14?/m1/s1

Upstream product

• 98-88-4 benzoyl chloride 

Relevant articles and documents

Novel cytarabine monophosphate prodrugs

Compounds of Formula I, their preparation and uses are described: wherein: M and V are cis to one another and MH is cytarabine; the 5′ oxygen of said cytarabine is attached to the phosphorus; V is 4-pyridyl; and pharmaceutically acceptable prodrugs and salts thereof.